JPS59190917A - 補給用電解質溶液 - Google Patents
補給用電解質溶液Info
- Publication number
- JPS59190917A JPS59190917A JP6450283A JP6450283A JPS59190917A JP S59190917 A JPS59190917 A JP S59190917A JP 6450283 A JP6450283 A JP 6450283A JP 6450283 A JP6450283 A JP 6450283A JP S59190917 A JPS59190917 A JP S59190917A
- Authority
- JP
- Japan
- Prior art keywords
- salt
- phosphate
- citric acid
- electrolytic solution
- magnesium
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000008151 electrolyte solution Substances 0.000 title claims abstract description 11
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims abstract description 45
- 150000003839 salts Chemical class 0.000 claims abstract description 13
- 229910019142 PO4 Inorganic materials 0.000 claims abstract description 9
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims abstract description 9
- 239000010452 phosphate Substances 0.000 claims abstract description 5
- 159000000003 magnesium salts Chemical class 0.000 claims description 11
- 229940021013 electrolyte solution Drugs 0.000 claims description 7
- 229960002261 magnesium phosphate Drugs 0.000 claims description 4
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 abstract description 16
- 229910001629 magnesium chloride Inorganic materials 0.000 abstract description 8
- 239000007864 aqueous solution Substances 0.000 abstract description 7
- 229910001425 magnesium ion Inorganic materials 0.000 abstract description 6
- 239000000243 solution Substances 0.000 abstract description 3
- 206010021027 Hypomagnesaemia Diseases 0.000 abstract description 2
- 206010012601 diabetes mellitus Diseases 0.000 abstract description 2
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 abstract description 2
- 239000001095 magnesium carbonate Substances 0.000 abstract description 2
- 229910000021 magnesium carbonate Inorganic materials 0.000 abstract description 2
- 229910000403 monosodium phosphate Inorganic materials 0.000 abstract description 2
- 235000019799 monosodium phosphate Nutrition 0.000 abstract description 2
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 abstract description 2
- 239000011777 magnesium Substances 0.000 abstract 4
- 230000001376 precipitating effect Effects 0.000 abstract 3
- QXNVGIXVLWOKEQ-UHFFFAOYSA-N Disodium Chemical compound [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 abstract 1
- 208000019423 liver disease Diseases 0.000 abstract 1
- 125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 abstract 1
- 229940085991 phosphate ion Drugs 0.000 abstract 1
- 238000001556 precipitation Methods 0.000 description 9
- 229960002337 magnesium chloride Drugs 0.000 description 7
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 6
- 235000019796 monopotassium phosphate Nutrition 0.000 description 6
- 235000021317 phosphate Nutrition 0.000 description 6
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 6
- PJNZPQUBCPKICU-UHFFFAOYSA-N phosphoric acid;potassium Chemical compound [K].OP(O)(O)=O PJNZPQUBCPKICU-UHFFFAOYSA-N 0.000 description 6
- 230000001954 sterilising effect Effects 0.000 description 6
- 238000004659 sterilization and disinfection Methods 0.000 description 6
- JLVVSXFLKOJNIY-UHFFFAOYSA-N Magnesium ion Chemical compound [Mg+2] JLVVSXFLKOJNIY-UHFFFAOYSA-N 0.000 description 5
- 239000002244 precipitate Substances 0.000 description 5
- 230000015572 biosynthetic process Effects 0.000 description 4
- 210000001124 body fluid Anatomy 0.000 description 3
- 239000010839 body fluid Substances 0.000 description 3
- 239000012153 distilled water Substances 0.000 description 3
- 235000017281 sodium acetate Nutrition 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- BDKLKNJTMLIAFE-UHFFFAOYSA-N 2-(3-fluorophenyl)-1,3-oxazole-4-carbaldehyde Chemical compound FC1=CC=CC(C=2OC=C(C=O)N=2)=C1 BDKLKNJTMLIAFE-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 229940050906 magnesium chloride hexahydrate Drugs 0.000 description 2
- DHRRIBDTHFBPNG-UHFFFAOYSA-L magnesium dichloride hexahydrate Chemical compound O.O.O.O.O.O.[Mg+2].[Cl-].[Cl-] DHRRIBDTHFBPNG-UHFFFAOYSA-L 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 229940087562 sodium acetate trihydrate Drugs 0.000 description 2
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 2
- LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 2
- 208000022309 Alcoholic Liver disease Diseases 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- LUVOJBWJNHWVNG-UHFFFAOYSA-N [Na].[Na].[Na].OC(=O)CC(O)(C(O)=O)CC(O)=O Chemical compound [Na].[Na].[Na].OC(=O)CC(O)(C(O)=O)CC(O)=O LUVOJBWJNHWVNG-UHFFFAOYSA-N 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 1
- 229910000396 dipotassium phosphate Inorganic materials 0.000 description 1
- 235000019797 dipotassium phosphate Nutrition 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000002526 disodium citrate Substances 0.000 description 1
- 235000019262 disodium citrate Nutrition 0.000 description 1
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 1
- CEYULKASIQJZGP-UHFFFAOYSA-L disodium;2-(carboxymethyl)-2-hydroxybutanedioate Chemical compound [Na+].[Na+].[O-]C(=O)CC(O)(C(=O)O)CC([O-])=O CEYULKASIQJZGP-UHFFFAOYSA-L 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 210000002977 intracellular fluid Anatomy 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- UEGPKNKPLBYCNK-UHFFFAOYSA-L magnesium acetate Chemical compound [Mg+2].CC([O-])=O.CC([O-])=O UEGPKNKPLBYCNK-UHFFFAOYSA-L 0.000 description 1
- 239000011654 magnesium acetate Substances 0.000 description 1
- 229940069446 magnesium acetate Drugs 0.000 description 1
- 235000011285 magnesium acetate Nutrition 0.000 description 1
- 229960001708 magnesium carbonate Drugs 0.000 description 1
- 239000001755 magnesium gluconate Substances 0.000 description 1
- 229960003035 magnesium gluconate Drugs 0.000 description 1
- 235000015778 magnesium gluconate Nutrition 0.000 description 1
- OVGXLJDWSLQDRT-UHFFFAOYSA-L magnesium lactate Chemical compound [Mg+2].CC(O)C([O-])=O.CC(O)C([O-])=O OVGXLJDWSLQDRT-UHFFFAOYSA-L 0.000 description 1
- 239000000626 magnesium lactate Substances 0.000 description 1
- 229960004658 magnesium lactate Drugs 0.000 description 1
- 235000015229 magnesium lactate Nutrition 0.000 description 1
- GVALZJMUIHGIMD-UHFFFAOYSA-H magnesium phosphate Chemical compound [Mg+2].[Mg+2].[Mg+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O GVALZJMUIHGIMD-UHFFFAOYSA-H 0.000 description 1
- 239000004137 magnesium phosphate Substances 0.000 description 1
- 229910000157 magnesium phosphate Inorganic materials 0.000 description 1
- 235000010994 magnesium phosphates Nutrition 0.000 description 1
- IAKLPCRFBAZVRW-XRDLMGPZSA-L magnesium;(2r,3s,4r,5r)-2,3,4,5,6-pentahydroxyhexanoate;hydrate Chemical compound O.[Mg+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O IAKLPCRFBAZVRW-XRDLMGPZSA-L 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- 235000011083 sodium citrates Nutrition 0.000 description 1
- 239000001488 sodium phosphate Substances 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 229910000404 tripotassium phosphate Inorganic materials 0.000 description 1
- 235000019798 tripotassium phosphate Nutrition 0.000 description 1
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
- 229910000406 trisodium phosphate Inorganic materials 0.000 description 1
- 235000019801 trisodium phosphate Nutrition 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP6450283A JPS59190917A (ja) | 1983-04-14 | 1983-04-14 | 補給用電解質溶液 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP6450283A JPS59190917A (ja) | 1983-04-14 | 1983-04-14 | 補給用電解質溶液 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS59190917A true JPS59190917A (ja) | 1984-10-29 |
| JPH0559094B2 JPH0559094B2 (enrdf_load_html_response) | 1993-08-30 |
Family
ID=13260036
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP6450283A Granted JPS59190917A (ja) | 1983-04-14 | 1983-04-14 | 補給用電解質溶液 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS59190917A (enrdf_load_html_response) |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS56128711A (en) * | 1980-03-12 | 1981-10-08 | Hikari Seiyaku Kk | Glucose-electrolyte preparation for high-calorie transfusion |
| JPS57188511A (en) * | 1981-05-15 | 1982-11-19 | Tanabe Seiyaku Co Ltd | Stabilized electrolyte solution |
| JPS5916818A (ja) * | 1982-07-20 | 1984-01-28 | Shimizu Seiyaku Kk | 経静脈投与用輸液剤 |
-
1983
- 1983-04-14 JP JP6450283A patent/JPS59190917A/ja active Granted
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS56128711A (en) * | 1980-03-12 | 1981-10-08 | Hikari Seiyaku Kk | Glucose-electrolyte preparation for high-calorie transfusion |
| JPS57188511A (en) * | 1981-05-15 | 1982-11-19 | Tanabe Seiyaku Co Ltd | Stabilized electrolyte solution |
| JPS5916818A (ja) * | 1982-07-20 | 1984-01-28 | Shimizu Seiyaku Kk | 経静脈投与用輸液剤 |
Also Published As
| Publication number | Publication date |
|---|---|
| JPH0559094B2 (enrdf_load_html_response) | 1993-08-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TWI583378B (zh) | 透析酸前驅物組成物、其用途、以及提供透析酸濃縮物溶液之方法 | |
| US9216247B2 (en) | Buffered compositions for dialysis | |
| JP5975962B2 (ja) | 透析用緩衝化組成物 | |
| ES2450131T3 (es) | Soluciones de diálisis esterilizadas que contienen pirofosfato | |
| JP5204359B2 (ja) | 透析用剤およびその製造方法 | |
| US20090294360A1 (en) | Dialysis preparation | |
| TWI419683B (zh) | 骨代謝改善劑 | |
| US20170157172A1 (en) | Dialysis precursor composition | |
| WO1987003806A1 (en) | Parenteral nutrition therapy with amino acids | |
| JP3118258B2 (ja) | ジホスホン酸およびその塩を含有する医薬品 | |
| JP2001518497A (ja) | 医療用溶液の濃縮物及びその使用 | |
| JP6425661B2 (ja) | 透析組成物 | |
| JP2003339853A (ja) | 安定な透析用剤 | |
| JP3484689B2 (ja) | 微量元素製剤 | |
| JPS59190917A (ja) | 補給用電解質溶液 | |
| PT755396E (pt) | Solucao aquosa estavel de folinato | |
| JP5371278B2 (ja) | 透析用剤およびその製造方法 | |
| JP3572085B2 (ja) | 栄養輸液剤 | |
| JP2720165B2 (ja) | ぶどう糖電解質配合剤 | |
| US20110257090A1 (en) | Solutions for volume therapy | |
| JP3643879B2 (ja) | 電解質輸液組成物 | |
| EP1318821B1 (en) | Fluid for haemofiltration | |
| CA1304688C (en) | Fluid therapy with 1-lactate and/or pyruvate anions | |
| RU2190411C2 (ru) | Инъекционная форма препарата, проявляющего противоишемическую активность | |
| JP4320795B2 (ja) | 栄養輸液剤 |